Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples
https://doi.org/10.18093/0869-0189-2020-30-5-715-722
Abstract
At the end of 2019, an outbreak of a new coronavirus infection was identified in the People’s Republic of China centerd in the city of Wuhan. The official name COVID-19 (COronaVIrus Disease 2019) was assigned to the infection caused by the novel coronavirus by the World Health Organization on February 11, 2020. The International Committee on Taxonomy of Viruses assigned the name to the causative agent of the infection – SARS-CoV-2 on February 11, 2020. The bilateral pneumonia is currently known to be the most common clinical manifestation of the variant of coronavirus infection. The development of acute respiratory distress syndrome was found in 3 – 4% of patients. As a result of pneumonia, patients develop ventilation and perfusion disorders, weakness of skeletal muscles. To recover patients after viral pneumonia, methods of pulmonary rehabilitation should be applied. This article represents the methods of pulmonary rehabilitation aimed to improve the blood circulation in the lungs, the ventilation-perfusion ratios, and to the restoration of the skeletal muscles.
About the Authors
N. N. Meshcheryakova
N.I.Pirogov Federal Russian National Research Medical University, Healthcare Ministry of Russia; “IntegraMed” Respiratory Medicine Clinic
Russian Federation
Russian Federation
Natalya N. Meshcheryakova – Candidate of Medicine, Associate Professor of the Department of Pulmonology, Faculty of Postgraduate Physician Training, N.I.Pirogov Russian National Research Medical University, Healthcare Ministry of Russia; pulmonologist at “IntegraMed” Respiratory Medicine Clinic
Ostrovityanova 1, Moscow, 117997
Mazhorov per. 7, Moscow, 107023
tel.: (903) 744-24-63
A. S. Belevskiy
N.I.Pirogov Federal Russian National Research Medical University, Healthcare Ministry of Russia
Russian Federation
Russian Federation
Andrey S. Belevsky – Doctor of Medicine, Professor, Head of the Department of Pulmonology, Faculty of Postgraduate Physician Training
Ostrovityanova 1, Moscow, 117997
tel.: (495) 963-24-67
A. V. Kuleshov
“IntegraMed” Respiratory Medicine Clinic
Russian Federation
Russian Federation
Andrey V. Kuleshov – Candidate of Medicine, Chief Physician
Mazhorov per. 7, Moscow, 107023
tel.: (903) 130-59-02
References
1. Ministry of Health of the Russian Federation. [Temporary guidelines: Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (03.06.2020)]. Available at: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf (in Russian).
2. Baig A.M. Khaleeq A., Ali U. et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020; 11 (7): 995–998. DOI: 10.1021/acschemneuro.0c00122.
3. Behzadi M.A., Leyva-Grado V.H. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and Middle East respiratory syndrome coronavirus infections. Front. Microbiol. 2019; 10: 1327. DOI: 10.3389/fmicb.2019.01327.
4. Covernment of Canada. Coronavirus disease (COVID-19): Symptoms and treatment. Available at: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/symptoms.html
5. CDC: Center for Disease Control and Prevention. Coronavirus disease 2019. Available at: https://www.cdc.gov/coronavirus/2019-ncov/index.html
6. Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223): 507–513. DOI: 10.1016/S0140-6736(20)30211-7.
7. Nici L., Donner C., Wouters E. et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173 (12): 1390–1413. DOI: 10.1164/rccm.200508-1211st.
8. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Update 2013. Available at: https://goldcopd.org/
9. Isaev G.G. [Respiratory muscle physiology]. In: Breslav I.S., Isaev G.G., eds. [Respiratory Physiology]. St. Petersburg: Nauka; 1994: 178–197 (in Russian).
10. McConnell A. Breathe Strong Perform Better. Human Kinetics; 2011.
11. American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am. J. Respir. Crit. Care Med. 2002; 166 (4): 518–624. DOI: 10.1164/rccm.166.4.518.
12. Black L.F., Hyatt R.E. Maximal inspiratory pressures: normal values and relationship to age and sex. Am. Rev. Respir. Dis. 1969; 99: 696–702.
13. Caine M.P., McConnell A.K. Development and evaluation of a pressure threshold inspiratory muscle trainer for use in the context of sports performance. J. Sports Engineer. 2000; 3 (3): 149–159. DOI: 10.1046/j.1460-2687.2000.00047.x.
14. Edwards A.M., Wells C., Butterly R. Concurreny inspiratory muscle and cardiovascular training differentially improves both perceptions of effort and 5000 m running performance compared with cardiovascular training alone. Br. J. Sports Med. 2004; 42 (10): 523–527. DOI: 10.1136/bjsm.2007.045377.
15. Enright S.J., Unnithan V.B., Heward C. et al. Effect of high-intensity inspiratory muscle training on lung volumes, diaphragm thickness, and exercise capacity in subjects who are healthy. Phys. Ther. 2006; 86 (3): 345–354. DOI: 10.1093/ptj/86.3.345.
16. Epstein S.K. An overview of respiratory muscle function. Clin. Chest. Med. 1994; 15 (4): 619–639.
17. Gregory C.M., Bickel C.S. Recruitment pattern in Himan skeletal muscle during electrical stimulation. Phys. Ther. 2005; 85 (4): 358–364. DOI: 10.1093/ptj/85.4.358.
18. Requena Sánchez B., Padial Puche P., Gonzalez-Badillo J.J. Percutaneous electrical stimulation in strength training: an update. J. Strength Cond. Res. 2005; 19 (2): 438–441.
19. Geddes E.L., O’Brien K., Reid W.D. et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir. Med. 2008; 102 (12): 1715–1729. DOI: 10.1016/j.rmed.2008.07.005.
20. Gosselink R., De Vos J., van den Heuvel S.P. et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur. Respir. J. 2011; 37 (2): 416–425. DOI: 10.1183/09031936.00031810.
21. O’Brien K., Geddes E.L., Reid W.D. et al. Inspiratory muscle training compared with other rehabilitation interventions in chronic obstructive pulmonary disease: A systematic review update. J. Cardiopulm. Rehabil. Prev. 2008; 28 (2): 128–141. DOI: 10.1097/01.hcr.0000314208.40170.00.
22. Lötters F., van Tol B., Kwakkel G. et al. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur. Respir. J. 2002; 20 (3): 570–576. DOI: 22. Lötters F., van Tol B., Kwakkel G. et al. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur. Respir. J. 2002; 20 (3): 570–576. DOI: 10.1183/09031936.02.00237402.
23. Hill K., Jenkins S.C., Philippe D.L. et al. High-intensity inspiratory muscle training in COPD. Eur. Respir. J. 2006; 27 (6): 1119–1128.
24. Meshcheriakova N., Belevskiy A., Cherniak A. et al. Threshold PEP and IMT devices (PID) for COPD patient respiratory training. Eur. Respir. J. [Abstracts 16 th ERS Annual Congress. Munich, Germany, 2–6 September, 2006]. 2006; 28 (Suppl. 50): S553.
25. Kempainen R.R., Milla C., Duniz J. et al. Comparison of setting used for high-freguency chest-wall compression in cyctic fibrosis. Respir. Care. 2010; 55 (6): 782–783.
26. Allan J.S., Garrity G.M., Donahue D.M. High-freguency chest-wall compression during the 48 hours following thoracic surgery. Respir. Care. 2009; 54 (3): 340–343.
27. Nicolini A., Cardini F., Landucci N. et al. Effectiveness of treatment with high-frequency chest wall ascillation in patients with bronchiectasis. BMC Pulm. Med. 2013; 13 (1): 21. DOI: 10.1186/1471-2466-13-21.
28. Gloeck R., Heinzeimann I., Baeuerle S. et al. Effects of whole body vibration in patients with chronic obstructive pulmonary disease: A randomized controlled trial. Respir. Med. 2012; 106 (1): 75–83. DOI: 10.1016/j.rmed.2011.10.021.
29. Brugliera L., Spina A., Castellazzi P. et al. Rehabilitation of COVID-19 patients. J. Rehabil. Med. 2020; 52 (4): jrmo00046. DOI: 10.2340/16501977-2678.
30. Bryant M.S., Fedson S.E., Sharafkhaneh A. Using telehealth cardiopulmonary rehabilitation during the COVID-19 pandemic. J. Med. Syst. 2020; 44 (7): 125. DOI: 10.1007/s10916-020-01593-8.
31. De Biase S., Cook L., Skelton D.A. et al. The COVID-19 rehabilitation pandemic. Age Ageing. 2020; 49 (5): 696–700. DOI: 10.1093/ageing/afaa118.
32. Bettger J.P., Thoumi A., Marguevich W. et al. COVID-19: maintain essential rehabilitation services across the care continuum. BMJ Glob. Heath. 2020; 5 (5): e002670. DOI: 10.1136/bmjgh-2020-002670.
33. Carda S., Invernizzi M., Bavikatte G. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann. Phys. Rehabil. Med. 2020; 99 (6): 459–463. DOI: 10.1097/phm.0000000000001452.
Review
For citations:
Meshcheryakova N.N., Belevskiy A.S., Kuleshov A.V. Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples. PULMONOLOGIYA. 2020;30(5):715-722. https://doi.org/10.18093/0869-0189-2020-30-5-715-722
Views:
4449
Email this article 